Matteo Landriscina

Matteo Landriscina

Università degli Studi di Foggia

H-index: 46

Europe-Italy

About Matteo Landriscina

Matteo Landriscina, With an exceptional h-index of 46 and a recent h-index of 30 (since 2020), a distinguished researcher at Università degli Studi di Foggia, specializes in the field of Clinical Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

Tumor treating fields for the treatment of glioblastoma: Current understanding and future perspectives

1635P Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic ductal adenocarcinoma patients

Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Cytosolic and mitochondrial translation elongation are coordinated through the molecular chaperone TRAP1 for the synthesis and import of mitochondrial proteins

Matteo Landriscina Information

University

Position

___

Citations(all)

6334

Citations(since 2020)

2740

Cited By

4678

hIndex(all)

46

hIndex(since 2020)

30

i10Index(all)

97

i10Index(since 2020)

74

Email

University Profile Page

Università degli Studi di Foggia

Google Scholar

View Google Scholar Profile

Matteo Landriscina Skills & Research Interests

Clinical Oncology

Top articles of Matteo Landriscina

Title

Journal

Author(s)

Publication Date

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

Targeted Oncology

Margherita Rimini

Gianluca Masi

Sara Lonardi

Federico Nichetti

Tiziana Pressiani

...

2024/5/1

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Brigida Anna Maiorano

Massimo Di Maio

Linda Cerbone

Evaristo Maiello

Giuseppe Procopio

...

2024/3/4

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

Prostate Cancer and Prostatic Diseases

Vincenza Conteduca

Piergiorgio Di Tullio

Rossana Allamprese

Giuseppina Bruno

Cristian Lolli

...

2024/2/12

Tumor treating fields for the treatment of glioblastoma: Current understanding and future perspectives

Antonio Colamaria

Augusto Leone

Nicola Pio Fochi

Veronica Di Napoli

Guido Giordano

...

2023

1635P Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic ductal adenocarcinoma patients

Annals of Oncology

G Orsi

C Carconi

P Ghiorzo

L Pastorino

M Chiaravalli

...

2023/10/1

Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer

The Oncologist

Guido Giordano

Raffaele Ivan Cincione

Francesca Losavio

Tiziano Senia

Arianna Aquilini Mummolo

...

2023/9/1

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Liver International

Margherita Rimini

Lorenzo Fornaro

Sara Lonardi

Monica Niger

Daniele Lavacchi

...

2023/8

Cytosolic and mitochondrial translation elongation are coordinated through the molecular chaperone TRAP1 for the synthesis and import of mitochondrial proteins

Genome Research

Rosario Avolio

Ilenia Agliarulo

Daniela Criscuolo

Daniela Sarnataro

Margherita Auriemma

...

2023/8/1

Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis

Giuseppe Bronte

Vincenza Conteduca

Matteo Landriscina

Antonio Domenico Procopio

2023/3

Multidisciplinary management of HER2-positive breast cancer with brain metastases: an evidence-based pragmatic approach moving from pathophysiology to clinical data

Guido Giordano

Gaia Griguolo

Matteo Landriscina

Icro Meattini

Francesco Carbone

...

2023/10/18

Are we ready to implement molecular subtyping of bladder cancer in clinical practice? Part 2: subtypes and divergent differentiation

Francesca Sanguedolce

Magda Zanelli

Andrea Palicelli

Stefano Ascani

Maurizio Zizzo

...

2022/7/16

Solitary fibrous tumor/hemangiopericytoma of the cervical spine: A systematic review of the literature with an illustrative case

Journal of Neuro-Oncology

Connor J Kinslow

Samuel S Bruce

Ali I Rae

Sameer A Sheth

Guy M McKhann

...

2018/5

TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation

International Journal of Oncology

Giuseppina Bruno

Valeria Li Bergolis

Annamaria Piscazzi

Fabiana Crispo

Valentina Condelli

...

2022/6/1

Solitary metastasis from renal cell carcinoma to the choroid plexus: A case illustration and review of the literature

Antonio Colamaria

Maria Blagia

Matteo Sacco

Savino Iodice

Francesco Carbone

...

2022

Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells

Cancer Cell International

Danilo Swann Matassa

Daniela Criscuolo

Rosario Avolio

Ilenia Agliarulo

Daniela Sarnataro

...

2022/12/12

Differential and divergent activity of insulin‑like growth factor binding protein 6 in platinum‑sensitive versus platinum‑resistant high‑grade serous ovarian carcinoma cell lines

Oncology Letters

Annamaria Piscazzi

Valentina Condelli

Fabiana Crispo

Anna Rita Daniela Coda

Giovanni Calice

...

2022/6/1

Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet …

Frontiers in Oncology

Alessandro Parisi

Riccardo Giampieri

Alex Mammarella

Cristiano Felicetti

Lisa Salvatore

...

2022/8/12

Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancer

Cancer Cell International

Francesca Pia Caruso

Mario Rosario D’Andrea

Luigi Coppola

Matteo Landriscina

Valentina Condelli

...

2022/8/11

The classification of neuroendocrine neoplasms of the lung and digestive system according to WHO: similarities, differences, challenges, and unmet needs.

Francesca Sanguedolce

Magda Zanelli

Andrea Palicelli

Alberto Cavazza

M Zizzo

...

2022/2/11

What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review (part 6): correlation of PD-L1 expression with the status of mismatch repair …

Andrea Palicelli

Martina Bonacini

Stefania Croci

Cristina Magi-Galluzzi

Sofia Cañete-Portillo

...

2021/11/14

See List of Professors in Matteo Landriscina University(Università degli Studi di Foggia)